UBS Share Price Hits Record €45.05 Despite Escalating $20 Billion Capital Dispute With SNB
Published on 07/04/2026 at 17:29 | Redaktion boerse-global.de
The UBS share price brushed aside a rare public battle between the Swiss National Bank and the bank’s management to mark an all-time high of €45.05 on Tuesday. By Friday’s close the stock had settled at €44.59, leaving it up more than 50 percent for the past twelve months and over 20 percent above its 200-day moving average. Yet behind the rally lies a deepening rift over how much capital the country’s largest lender must hold from 2030.
The SNB publicly backed a government proposal that would force UBS to raise an additional $20 billion in core equity tier one capital — a direct consequence of the bank’s enlarged balance sheet after absorbing Credit Suisse. The central bank argued that UBS already exceeds current requirements by $13 billion and held a further $9 billion in reserves at the end of 2025, making a seven?year transition period comfortable without touching future dividends. But UBS management pushed back sharply, warning that such a buffer would create a “massive competitive disadvantage” on the international stage and internally estimates the real capital shortfall could indeed hit around $20 billion.
The political machinery is already in motion. The Swiss parliament is scheduled to vote on the new capital rules in August, with regulators finalising the framework in the interim. Until that decision lands, the stock’s resilience around its record high is being read as a vote of confidence that the final rules will be less punitive than feared.
Strong operational momentum cushions the regulatory noise
While the capital debate simmers, UBS’s underlying performance continues to impress. First?quarter 2026 net profit surged 80 percent year?on?year to $3.04 billion on revenue of $14.24 billion, driven by the ongoing integration of Credit Suisse. The bank still expects to realise $11.5 billion in cost savings from the merger, and its CET1 surplus against existing rules stands at $13 billion — giving it ample room even under the stricter regime if phased in gradually.
Should investors sell immediately? Or is it worth buying UBS?
The expansion story also has a new chapter: the US?wealth?management push. UBS plans to test banking products with its own employees from December 2026, followed by a full roll?out to affluent clients with investable assets of $2 million to $10 million in summer 2027. Winning market share in that high?margin segment could materially lift the bank’s valuation, though the US pre?tax margin of under 13 percent in 2025 still trails rivals such as Morgan Stanley.
Technicals point to strength — but analysts remain cautious
The chart has turned decisively bullish. The stock trades 21.1 percent above its 200?day line of €36.83 and 9.2 percent above the 50?day average of €40.84. In the past 30 days alone it has climbed 9.5 percent. The relative strength index currently sits at 64.2, approaching overbought territory and raising the risk of short?term profit?taking.
Yet analyst sentiment remains tempered. The consensus shows only one Hold and one Sell rating, reflecting scepticism that the rally can extend much further without a clearer resolution on capital. After a 52.9 percent surge from the 52?week low of €29.17, many experts see a pause as overdue. The average price target of €51.93 implies roughly 16.5 percent upside from Friday’s close, but that depends on a clean break above the €45.05 resistance.
UBS at a turning point? This analysis reveals what investors need to know now.
What to watch next
Key levels are now well defined. As long as the stock holds above the 50?day line at €40.84, the constructive picture remains intact. A decisive move above the all?time high could open the path toward the analyst target, while any sharp deterioration in the regulatory mood might pull the stock back toward the €40 support.
In the near term, the Swiss franc’s direction and US interest?rate expectations will influence both currency translation and net interest margin. The next strategic milestone comes in Q4 2026 when UBS launches its US product pilot with employees, but the August parliamentary vote on capital rules is the single biggest catalyst on the horizon. For now, the market is betting that UBS will find a way to keep growing despite the regulatory headache.
Ad
UBS Stock: New Analysis - 4 July
Fresh UBS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
